Extension of Time to File SOU

VELSIPITY

Arena Pharmaceuticals, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88491734
LAW OFFICE ASSIGNED LAW OFFICE 124
MARK SECTION
MARK VELSIPITY (see, http://uspto.report/TM/88491734/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT VELSIPITY
OWNER SECTION (current)
NAME Arena Pharmaceuticals, Inc.
MAILING ADDRESS 6154 Nancy Ridge Drive
CITY San Diego
STATE California
ZIP/POSTAL CODE 92121
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Arena Pharmaceuticals, Inc.
MAILING ADDRESS 6154 Nancy Ridge Drive
CITY San Diego
STATE California
ZIP/POSTAL CODE 92121
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Allison Strickland Ricketts
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ricketts-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) antonucci-docket@fzlz.com
CORRESPONDENCE INFORMATION (proposed)
NAME Allison Strickland Ricketts
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ricketts-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER ARPI 1908455
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 06/16/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Shannon K. Carter/
SIGNATORY'S NAME Shannon K. Carter
SIGNATORY'S POSITION VP, Intellectual Property
DATE SIGNED 11/23/2021
SIGNATORY'S PHONE NUMBER N/A
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Tue Nov 23 14:20:59 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XX-2
0211123142059320360-88491
734-7818349c3fd21cd8daa5f
669c63129e57f0c9eb37a4ca0
9d88d2f097f9ec45-DA-20570
310-20211122163446823260



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: VELSIPITY (see, http://uspto.report/TM/88491734/mark.png)
SERIAL NUMBER: 88491734

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Arena Pharmaceuticals, Inc., having an address of
      6154 Nancy Ridge Drive
      San Diego, California 92121
      United States
      Email: XXXX
Proposed: Arena Pharmaceuticals, Inc., having an address of
      6154 Nancy Ridge Drive
      San Diego, California 92121
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 06/16/2020.

For International Class 005:
Current identification: Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Allison Strickland Ricketts
      PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): antonucci-docket@fzlz.com

Correspondence Information (proposed):
      Allison Strickland Ricketts
      PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Shannon K. Carter/      Date Signed: 11/23/2021
Signatory's Name: Shannon K. Carter
Signatory's Position: VP, Intellectual Property
Signatory's Phone: N/A
Signature method: Sent to third party for signature

PAYMENT: 88491734
PAYMENT DATE: 11/23/2021

Serial Number: 88491734
Internet Transmission Date: Tue Nov 23 14:20:59 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XX-2021112314205932
0360-88491734-7818349c3fd21cd8daa5f669c6
3129e57f0c9eb37a4ca09d88d2f097f9ec45-DA-
20570310-20211122163446823260




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed